An alternative medium to support sterility testing using the Growth Direct® Rapid Sterility System
Join this webinar to learn how a new single medium, Rapid Sterility Medium (RSM), performs as well as or better for the growth promotion of test microorganisms compared to compendial sterility test media.
First-in-class combination therapy authorised for endometriosis
The three-in-one oral daily tablet provides an additional treatment option to help women in the UK manage their endometriosis-associated pain.
Advancing NOX inhibitors for treating fibrotic diseases and cancer
This article explores the benefit of NOX inhibitors for fibrotic diseases and cancers and highlights the potential of Calliditas’ setanaxib.
New webinar: Simplify your move from a vial to a prefilled syringe
Join this webinar to learn how a new single medium, Rapid Sterility Medium (RSM), performs as well as or better for the growth promotion of test microorganisms compared to compendial sterility test media.
New WHO guidance to support manufacturers to reduce AMR risk
The recommendations offered in the guidance applies across different phases of manufacturing, from APIs, through to formulation and packaging.
Improving upstream fermentation with end-to-end automation
The automated system “significantly improved process control”, resulting in greater productivity of a small-molecule drug substance.
Innovative hypertension polypill study achieves “significant” outcomes
The triple pill demonstrated “impressive” blood pressure control for the participants compared to standard of care.
Sustainable PFAS-free synthesis for pharmaceutical compounds
The novel, environmentally-friendly synthesis strategy holds potential for manufacturing scale up, according to the research.
Mpox update – August 2024
This article discusses the impact of the recent mpox emergency, highlighting the industry’s response and potential vaccine candidates.
Novartis collaboration to innovate subcutaneous drug delivery
The multi-target agreement could enhance treatment convenience by improving subcutaneous administration options for patients.
Innovative pharma-government partnership to enhance UK clinical trials
The innovative programme supports the UK government’s objectives to boost clinical trials and increase competitiveness in life sciences.
AstraZeneca investment to increase biologic capacity in Sweden
The planned expansion is set to strengthen AstraZeneca’s capability to manufacture biologic medicines for patients globally.
European Commission licenses first treatment for acanthamoeba keratitis
Following its European approval, the small molecule treatment is set to become the standard of care for patients with the ultra-rare disease.
Semi-automatic method could provide “superior” bacterial characterisation analysis
The analysis technique offers “significant” advantages over traditional colony forming unit (CFU) counts, according to the paper.
Alzheimer’s drug milestone “bittersweet” for certain patients
The first new dementia therapy to be licensed in over 20 years, has for the first time, shown efficiency in delaying cognitive decline.
Are we set for the revised EU GMP Annex 1?
This blog is a summary of the key changes of relevance to primary packaging components
Innovative mass spec method may improve oligonucleotide therapeutic analysis
The nonIP-RP-LC-MS method provides an “easy, reliable, and cost-effective” approach for bioanalysing oligonucleotide therapies.
Harnessing the GLP-1R medicine wave
As a promising treatment for T2D and obesity, based on key trial data, the GLP-1R therapy market looks set to produce major sales up to 2030.
First-of-a-kind trial holds promise for obesity and pre-diabetes treatment
The treatment may reduce the risk of progression to type 2 diabetes in adults with pre-diabetes and obesity or who are overweight.
Enhancing cell proliferation in bioproduction with non-invasive technology
The method has potential in both biomanufacturing and production of autologous cell therapies, the research suggests.
Genmab appoints new EVP and Chief Technology Officer
The new member of Genmab’s Executive Committee brings over 30 years of international biopharmaceutical experience to the role.
Targeted therapies for chronic lymphocytic leukaemia in an evolving treatment landscape
Chief Medical Officer for Hematology, BeiGene, discusses the evolution of therapies for CLL and the promise of targeted treatments.
First-in-class therapy approved for chronic skin disease
The biologic targets a key driver of prurigo nodularis, with trial data demonstrating improved itch as well as skin nodules for patients.
Sustainable QC method for antimicrobial quantification
The new fluorimetric approach could help to mitigate clinical demand for the treatment of multidrug-resistant bacterial infections.
Innovative vaccine demonstrates sustained malaria immunisation in pregnancy
Follow up research to the presented findings could provide improved opportunities for preventing malaria in women during pregnancy.